DOES THE B FORM SELECTIVE MONO-AMINE OXIDASE INHIBITOR LOSE SELECTIVITY BY LONG-TERM TREATMENT

被引：65

作者：

EKSTEDT, B ^{[1
]}

MAGYAR, K ^{[1
]}

KNOLL, J ^{[1
]}

机构：

[1] SEMMELWEIS MED UNIV,DEPT PHARMACOL,BUDAPEST,HUNGARY

来源：

关键词：

D O I：

10.1016/0006-2952(79)90376-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：919 / 923

页数：5

共 18 条

[1] BIRKMAYER W, 1977, LANCET, V1, P439
[2] INHIBITION BY CLORGYLINE AND DEPRENYL OF DIFFERENT FORMS OF MONOAMINE-OXIDASE IN RAT-LIVER MITOCHONDRIA
EGASHIRA, T
EKSTEDT, B
ORELAND, L
[J]. BIOCHEMICAL PHARMACOLOGY, 1976, 25 (23) : 2583 - 2586
[3] ELSWORTH JD, NEUROPHARMACOLOGY
[4] MONOAMINE OXIDASE INHIBITORS AND L-DOPA
HUNTER, KR
BOAKES, AJ
LAURENCE, DR
STERN, GM
[J]. BRITISH MEDICAL JOURNAL, 1970, 3 (5719) : 388 - &
[5] Knoll J, 1972, Adv Biochem Psychopharmacol, V5, P393
[6] KNOLL J, 1978, BIOCHEM PHARMACOL, V27, P1739, DOI 10.1016/0006-2952(78)90550-6
[7] KNOLL J, 1968, ARZNEI-FORSCHUNG, V18, P109
[8] KNOLL J, 1965, ARCH INT PHARMACOD T, V155, P154
[9] KNOLL J, 1976, MONOAMINE OXIDASE IT, P135
[10] KNOLL J, 1976, NEURON CONCEPT TODAY, P109